CCA
TECH icon

Checchi Capital Advisers’s Bio-Techne TECH Stock Holding History

Checchi Capital Advisers’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-480
Closed -$14K – 1110
2016
Q2 		$14K Buy
480
+148
+45% +$3.81K ﹤0.01% 1236
2016
Q1 		$8K Buy
+332
New +$7.31K ﹤0.01% 1352

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Checchi Capital Advisers's TECH Position: Q3 2016 in Review

Checchi Capital Advisers sold out of Bio-Techne (TECH) in Q3 2016, closing a stake of 480 shares — an estimated $14K sold.

Checchi Capital Advisers first reported a position in TECH in Q1 2016 and held it in 2 quarters. The position peaked at $14K in Q2 2016. 293 funds tracked by Wall St. Rank hold TECH as of Q3 2016.

  • Checchi Capital Advisers reported no remaining Bio-Techne position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 480 Bio-Techne shares in Q3 2016, an estimated $14K.
  • Checchi Capital Advisers first reported a position in Bio-Techne in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's Bio-Techne position peaked at $14K in Q2 2016.
  • 293 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.